Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Patheon, Inc. | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Patheon, Inc.

Patheon has named Francisco R. Negron as vice president and general manager of its Puerto Rico operations.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Patheon has named Francisco R. Negron as vice president and general manager of its Puerto Rico operations. Mr. Negron will be based at the company’s Manati site.

Mr. Negron has more than 19 years of experience in the pharmaceutical industry. Most recently he served as global vice president for Novartis Consumer Health, OTC and Pharmaceutical Products, with a specific focus on global process improvement initiatives. He also served as vice president of manufacturing and supply for Valeant Pharmaceuticals and as site general manager for McNeil Consumer Healthcare in Piedras, PR.

“Franco is the right person at the right time to manage our organization in Puerto Rico,” said Mr. Wes Wheeler, Patheon’s chief executive officer and president. “His experience leading complex and highly efficient manufacturing teams for a variety of world class pharmaceutical organizations will help us transform our business in PR and will support our stated goal of creating a strong manufacturing presence in that region. He has my full support and I look forward to his contributions to Patheon in the future.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters